USP is meeting the needs of the industry now and in the future with new microbial contamination control solutions, through acquisition of Stratix Labs, a microbiology technology company based in Saint Paul, MN.
With the acquisition of Stratix Labs and its suite of ready-to-use products for microbiological quality control testing, USP will now offer reliable, efficient, and convenient tools to enhance microbial contamination control strategies in manufacturing and compounding settings. As demand grows and new modalities emerge, these tools—which are powered by Stratix Labs’ innovative microbial preservation technologies—will help ensure quality throughout the drug development, manufacturing, and preparation process.
Combining Stratix Labs’ microbial quality control tools with USP’s applicable quality standards, will further enhance the accuracy and reliability of microbial contamination control and sterility assurance strategies, boosting regulatory confidence and ensuring the quality and safety of drug products.